{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:43:02Z","timestamp":1792100582917,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA161294"],"award-info":[{"award-number":["1R01CA161294"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ijrobp.2018.08.046","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T07:47:49Z","timestamp":1536306469000},"page":"195-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer"],"prefix":"10.1016","volume":"103","author":[{"given":"Le","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milana","family":"Bochkur Dratver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Yazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bochkur Dratver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Duhachek-Muggy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kruttika","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Alli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Pajonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erina","family":"Vlashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.08.046_bib1","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple- negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib2","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib4","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/jnci\/djj495","article-title":"The response of CD24(\/low)\/CD44+ breast cancer-initiating cells to radiation","volume":"98","author":"Phillips","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1073\/pnas.0606599104","article-title":"WNT\/beta-catenin mediates radiation resistance of mouse mammary progenitor cells","volume":"104","author":"Woodward","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy","volume":"100","author":"Li","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jnci\/djn509","article-title":"In\u00a0vivo imaging, tracking, and targeting of cancer stem cells","volume":"101","author":"Vlashi","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2310\/7290.2015.00016","article-title":"Imaging reporters for proteasome activity identify tumor- and metastasis-initiating cells","volume":"14","author":"Stacer","year":"2015","journal-title":"Mol Imaging"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2407-14-152","article-title":"Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients","volume":"14","author":"Lagadec","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10549-013-2688-6","article-title":"Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression","volume":"141","author":"Vlashi","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib11","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.3892\/ijo.2014.2670","article-title":"Visualization and characterization of cancer stem-like cells in cervical cancer","volume":"45","author":"Hayashi","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib12","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3892\/ijo.2014.2671","article-title":"Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity","volume":"45","author":"Tamari","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.stemcr.2014.11.002","article-title":"A flexible reporter system for direct observation and isolation of cancer stem cells","volume":"4","author":"Tang","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/stem.1058","article-title":"Radiation-induced reprogramming of breast cancer cells","volume":"30","author":"Lagadec","year":"2012","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib15","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.yexcr.2010.04.030","article-title":"Up-regulation of the embryonic self-renewal network through reversible polyploidy in irradiated p53-mutant tumour cells","volume":"316","author":"Salmina","year":"2010","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib16","doi-asserted-by":"crossref","first-page":"e43628","DOI":"10.1371\/journal.pone.0043628","article-title":"Ionizing radiation induces stemness in cancer cells","volume":"7","author":"Ghisolfi","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-4598-12-94","article-title":"Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes","volume":"12","author":"Gomez-Casal","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/cdd.2010.150","article-title":"Acidic stress promotes a glioma stem cell phenotype","volume":"18","author":"Hjelmeland","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib19","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1073\/pnas.1018866109","article-title":"Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia","volume":"109","author":"Conley","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1073\/pnas.1018898108","article-title":"Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion","volume":"108","author":"Iliopoulos","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/cdd.2014.31","article-title":"Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy","volume":"21","author":"Auffinger","year":"2014","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0001-706X(02)00217-6","article-title":"Benzimidazole treatment of cystic echinococcosis","volume":"85","author":"El-On","year":"2003","journal-title":"Acta Tropica"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib23","first-page":"2963","article-title":"Mebendazole elicits a potent antitumor effect on human cancer cell lines both in\u00a0vitro and in\u00a0vivo","volume":"8","author":"Mukhopadhyay","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib24","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/1541-7786.MCR-07-2159","article-title":"Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells","volume":"6","author":"Doudican","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib25","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s00432-013-1539-5","article-title":"Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer","volume":"139","author":"Nygren","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib26","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/neuonc\/nor077","article-title":"Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme","volume":"13","author":"Bai","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib27","doi-asserted-by":"crossref","first-page":"N15","DOI":"10.1227\/01.neu.0000460594.93803.cb","article-title":"Repurposing mebendazole for the treatment of medulloblastoma","volume":"76","author":"Bodhinayake","year":"2015","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib28","doi-asserted-by":"crossref","first-page":"12968","DOI":"10.18632\/oncotarget.14673","article-title":"Anthelmintic mebendazole enhances cisplatin\u2019s effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC)","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3332\/ecancer.2014.485","article-title":"Repurposing Drugs in Oncology (ReDO)\u2014Mebendazole as an anti-cancer agent","volume":"8","author":"Pantziarka","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-14-0755-T","article-title":"Repurposing the antihelmintic mebendazole as a hedgehog inhibitor","volume":"14","author":"Larsen","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib31","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/cancers7030851","article-title":"Hedgehog signaling in the maintenance of cancer stem cells","volume":"7","author":"Cochrane","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib32","first-page":"181","article-title":"The hedgehog signaling network, mammary stem cells, and breast cancer: Connections and controversies","author":"Lewis","year":"2006","journal-title":"Ernst Schering Found Symp Proc"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.cdd.4401231","article-title":"Mitochondrial membrane potential regulates matrix configuration and cytochrome C release during apoptosis","volume":"10","author":"Gottlieb","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.canlet.2016.07.018","article-title":"Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells","volume":"380","author":"Pavlopoulou","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib35","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.18632\/oncotarget.3436","article-title":"Flubendazole, FDA- approved anthelmintic, targets breast cancer stem-like cells","volume":"6","author":"Hou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation","volume":"124","author":"Ichikawa","year":"2014","journal-title":"J Clinical Invest"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib37","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2018.03.008","article-title":"Cardiotoxicity associated with radiotherapy in breast cancer: A question-based review with current literatures","volume":"68","author":"Zhu","year":"2018","journal-title":"Can Treatment Rev"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib39","first-page":"142","article-title":"Repurposing of anthelminthics as anticancer drugs","volume":"2","author":"Hamilton","year":"2017","journal-title":"Oncomedicine"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib40","doi-asserted-by":"crossref","first-page":"12576","DOI":"10.18632\/oncotarget.14990","article-title":"The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma","volume":"8","author":"Simbulan-Rosenthal","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib41","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/CAD.0b013e3283648c69","article-title":"Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines","volume":"24","author":"Kralova","year":"2013","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib42","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1182\/blood-2009-09-243055","article-title":"The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma","volume":"115","author":"Spagnuolo","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib43","first-page":"1201","article-title":"The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells","volume":"1","author":"Sasaki","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0006-291X(80)90349-6","article-title":"Inhibition of tubulin polymerization by mebendazole","volume":"92","author":"Laclette","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib45","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0006-2952(85)90611-2","article-title":"Structure-activity relationships of benzimidazole carbamates as inhibitors of mammalian tubulin, in\u00a0vitro","volume":"34","author":"Lacey","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/bst0150059","article-title":"Microtubules as target organelles for benzimidazole anthelmintic chemotherapy","volume":"15","author":"Gull","year":"1987","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib47","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.tiv.2015.08.007","article-title":"The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model","volume":"29","author":"Pinto","year":"2015","journal-title":"Toxicol In\u00a0Vitro"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2119\/molmed.2017.00011","article-title":"Repurposing mebendazole as a replacement for vincristine for the treatment of brain tumors","volume":"23","author":"De Witt","year":"2017","journal-title":"Mol Med"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/nass\/42.1.53","article-title":"The interaction of benzimidazole compounds with DNA: Intercalation and groove binding modes","author":"Kubota","year":"1999","journal-title":"Nucleic Acids Symposium Ser"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib50","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.2174\/092986708785133013","article-title":"Medical implications of benzimidazole derivatives as drugs designed for targeting DNA and DNA associated processes","volume":"15","author":"Bhattacharya","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jphotobiol.2012.05.003","article-title":"Synthesis, characterization, biological studies (DNA binding, cleavage, antibacterial and topoisomerase I) and molecular docking of copper(II) benzimidazole complexes","volume":"114","author":"Arjmand","year":"2012","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fphar.2016.00057","article-title":"DNA damage response is involved in the developmental toxicity of mebendazole in zebrafish retina","volume":"7","author":"Sasagawa","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/neuonc\/nou234","article-title":"Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis","volume":"17","author":"Bai","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2018.08.046_bib54","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-14-2681","article-title":"Brain penetration and efficacy of different mebendazole polymorphs in a mouse brain tumor model","volume":"21","author":"Bai","year":"2015","journal-title":"Clin Cancer Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618336885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618336885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T04:49:09Z","timestamp":1604897349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618336885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0360301618336885"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.08.046","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.08.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}